XLO$8.55+7.01%
Xilio Therapeutics, Inc.
Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq
Mkt Cap:$56.26M
Float & O/S:
Inst Own:
DilutionScan read 22 of Xilio Therapeutics, Inc.'s SEC filings and found 10 warrant series, 2 ATM programs, 4 shelf registrations and 1 completed offering on file for XLO. The latest dilution event on file is ATM sales on Jun 30, 2026. Analysis updated Oct 7, 2026.
